Английская Википедия:Anna-Lise Williamson
Шаблон:Short description Шаблон:Use dmy dates Шаблон:Infobox scientist
Anna-Lise Williamson Шаблон:Post-nominals MASSAf is a Professor of Virology at the University of Cape Town.Шаблон:R Williamson obtained her PhD from the University of the Witwatersrand in 1985. Her area of expertise is human papillomavirus, but is also known on an international level for her work in developing vaccines for HIV. These vaccines have been introduce in phase 1 of clinical trial. Williamson has published more than 120 papers.Шаблон:R
Education
Williamson received a PhD at the University of the Witwatersrand in 1985. Her Ph.D. thesis was entitled "An Electron Microscopic and Immunocytochemical Study of Jaagsiekte".Шаблон:Sfn Williamson was also a fellow at the Royal Society of South AfricaШаблон:R and at the University of Cape Town.Шаблон:R
Accomplishments
Anna-Lise Williamson is the Director of University of the Cape Town vaccine Research group GLP. Her area of expertise and what she is best known for is Human Papillomavirus and HIV Vaccines.Шаблон:R
- Awarded a Chair in Vaccinology 2008 (South African Research Chairs Initiative)
- Head of World Health Organization human papillomavirus Labnet lab for the Africa Region
- Joint Head of University of Cape Town, National Institute for communicable Diseases, and National health Laboratory Service Molecular Epidemiology Laboratory
- Member of the South African HPV Advisory BoardШаблон:R
- Member of the Academy of Science of South Africa Шаблон:R
Contributions
Anna-Lise Williamson is the head of the HIV vaccine development and human papilloma research group at the University of Cape Town. There, Williamson and a team of over 30 people are developing vaccines for HIV-1 subtype C virus. This strain is known to be the most Virulent,Шаблон:R and known to be the principle strain that leads to AIDS.The goal of the investigation is to create affordable and effective HIV-1 C vaccines,Шаблон:R that would increase the longevity of memory T cells and develop a more functional use of the CD4+ and CD8+ cell response.Шаблон:R Two vaccines have been selected to move forward in clinical trials. These vaccines are DNA vaccines and a modified vaccinia virus Ankara vaccine. The vaccines were developed as part of the South African AIDS Vaccine Initiative (SAAVI).Шаблон:R
Selected publications
Anna-Lise Williamson has published over 120 papers. Her publications mainly consists of her area of expertise addressing HIV vaccine development, HIV virus, and HPV virus.
- Шаблон:Cite journalThe purpose of this publication is to identify subtypes of HIV-1 in both homosexual and heterosexual males in the Cape Town, South Africa population.Шаблон:R
- Шаблон:Cite journalThe goal of this publication is to identify the prevalence and risk factors associated with HPV Infection, and HPV-16 antibody in the population of Southern Africa.
- Шаблон:Cite journal
- Шаблон:Cite journal
- Шаблон:Cite journalШаблон:R
References
Sources
External links
- Шаблон:ResearchGate
- Anna-Lise Williamson's Profile at Institute of Infectious Disease and Molecular Medicine, UCT
- Anna-Lise Williamson's Profile at the Department of Medical Virology, UCT
- Английская Википедия
- Year of birth missing (living people)
- Living people
- South African virologists
- Academic staff of the University of Cape Town
- University of the Witwatersrand alumni
- South African women scientists
- 21st-century women scientists
- Fellows of the Royal Society of South Africa
- Members of the Academy of Science of South Africa
- Страницы, где используется шаблон "Навигационная таблица/Телепорт"
- Страницы с телепортом
- Википедия
- Статья из Википедии
- Статья из Английской Википедии
